Linezolid lock prophylaxis of central venous catheter infection

References

1. Carratala J., Niubo J., Fernandez-Sevilla A., Juve E., Castellsague X., Berlanga J., Linares J., Gudiol F. 1999; Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 43:2200–2204
   [Google Scholar]
2. Castagnola E., Moroni C., Gandullia P., Oddone M., Peri C., Casciaro R., De Alessandri A. 2006; Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother 50:1120–1121 [CrossRef]
   [Google Scholar]
3. Centers for Disease Control and Prevention; 2005; Reduction in central line-associated bloodstream infections among patients in intensive care units –. Pennsylvania: April 2001–March 2005 MMWR Morb Mortal Wkly Rep 54:1013–1016
   [Google Scholar]
4. Cha R., Brown W. J., Rybak M. J. 2003; Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 47:3960–3963 [CrossRef]
   [Google Scholar]
5. Curtin J., Cormican M., Fleming G., Keelehan J., Colleran E. 2003; Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47:3145–3148 [CrossRef]
   [Google Scholar]
6. Garland J. S., Alex C. P., Henrickson K. J., McAuliffe T. L., Maki D. G. 2005; A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 116:e198–e205 [CrossRef]
   [Google Scholar]
7. LaPlante K. L., Mermel L. A. 2007; In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22:2239–2246 [CrossRef]
   [Google Scholar]
8. Mermel L. A., Farr B. M., Sherertz R. J., Raad I. I., O'Grady N., Harris J. S., Craven D. E. 2001; Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249–1272 [CrossRef]
   [Google Scholar]
9. O'Grady N. P., Alexander M., Dellinger E. P., Gerberding J. L., Heard S. O., Maki D. G., Masur H., McCormick R. D., Mermel L. A. other authors 2002; Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35:1281–1307 [CrossRef]
   [Google Scholar]
10. Onder A. M., Kato T., Simon N., Rivera-Hernandez M., Chandar J., Montane B., Francoeur D., Salvaggi G., Tzakis A. G., Zilleruelo G. 2007; Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters. Pediatr Transplant 11:87–93 [CrossRef]
    [Google Scholar]
11. Pronovost P., Needham D., Berenholtz S., Sinopoli D., Chu H., Cosgrove S., Sexton B., Hyzy R., Welsh R. other authors 2006; An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355:2725–2732 [CrossRef]
    [Google Scholar]
12. Raad I., Hanna H., Jiang Y., Dvorak T., Reitzel R., Chaiban G., Sherertz R., Hachem R. 2007; Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51:1656–1660 [CrossRef]
    [Google Scholar]
13. Safdar N., Maki D. G. 2006; Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43:474–484 [CrossRef]
    [Google Scholar]